Other
RougeTx
RougeTx
A biotech company developing drugs that restore the stability of blood vessels.
Naarden, Netherlands. A spin-out of Leiden University Medical Center.
Launched with a 58 million dollar Series A on 6 October 2026.
Written by our editors from public sources, linked in our story. Not a paid placement. Founders can request a correction.